Cargando…
Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution
Antibiotic resistance is expected by the WHO to be the biggest threat to human health before 2050. In this overview, we argue that this prediction may in fact be too optimistic because it is often overlooked that many bacterial infections frequently ‘go under the radar’ because they are difficult to...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944626/ https://www.ncbi.nlm.nih.gov/pubmed/35326882 http://dx.doi.org/10.3390/antibiotics11030419 |
_version_ | 1784673762197635072 |
---|---|
author | La Rosa, Ruggero Johansen, Helle Krogh Molin, Søren |
author_facet | La Rosa, Ruggero Johansen, Helle Krogh Molin, Søren |
author_sort | La Rosa, Ruggero |
collection | PubMed |
description | Antibiotic resistance is expected by the WHO to be the biggest threat to human health before 2050. In this overview, we argue that this prediction may in fact be too optimistic because it is often overlooked that many bacterial infections frequently ‘go under the radar’ because they are difficult to diagnose and characterize. Due to our lifestyle, persistent infections caused by opportunistic bacteria—well-known or emerging—show increasing success of infecting patients with reduced defense capacity, and often antibiotics fail to be sufficiently effective, even if the bacteria are susceptible, leaving small bacterial populations unaffected by treatment in the patient. The mechanisms behind infection persistence are multiple, and therefore very difficult to diagnose in the laboratory and to treat. In contrast to antibiotic resistance associated with acute infections caused by traditional bacterial pathogens, genetic markers associated with many persistent infections are imprecise and mostly without diagnostic value. In the absence of effective eradication strategies, there is a significant risk that persistent infections may eventually become highly resistant to antibiotic treatment due to the accumulation of genomic mutations, which will transform colonization into persistence. |
format | Online Article Text |
id | pubmed-8944626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89446262022-03-25 Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution La Rosa, Ruggero Johansen, Helle Krogh Molin, Søren Antibiotics (Basel) Opinion Antibiotic resistance is expected by the WHO to be the biggest threat to human health before 2050. In this overview, we argue that this prediction may in fact be too optimistic because it is often overlooked that many bacterial infections frequently ‘go under the radar’ because they are difficult to diagnose and characterize. Due to our lifestyle, persistent infections caused by opportunistic bacteria—well-known or emerging—show increasing success of infecting patients with reduced defense capacity, and often antibiotics fail to be sufficiently effective, even if the bacteria are susceptible, leaving small bacterial populations unaffected by treatment in the patient. The mechanisms behind infection persistence are multiple, and therefore very difficult to diagnose in the laboratory and to treat. In contrast to antibiotic resistance associated with acute infections caused by traditional bacterial pathogens, genetic markers associated with many persistent infections are imprecise and mostly without diagnostic value. In the absence of effective eradication strategies, there is a significant risk that persistent infections may eventually become highly resistant to antibiotic treatment due to the accumulation of genomic mutations, which will transform colonization into persistence. MDPI 2022-03-21 /pmc/articles/PMC8944626/ /pubmed/35326882 http://dx.doi.org/10.3390/antibiotics11030419 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Opinion La Rosa, Ruggero Johansen, Helle Krogh Molin, Søren Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution |
title | Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution |
title_full | Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution |
title_fullStr | Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution |
title_full_unstemmed | Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution |
title_short | Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution |
title_sort | persistent bacterial infections, antibiotic treatment failure, and microbial adaptive evolution |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944626/ https://www.ncbi.nlm.nih.gov/pubmed/35326882 http://dx.doi.org/10.3390/antibiotics11030419 |
work_keys_str_mv | AT larosaruggero persistentbacterialinfectionsantibiotictreatmentfailureandmicrobialadaptiveevolution AT johansenhellekrogh persistentbacterialinfectionsantibiotictreatmentfailureandmicrobialadaptiveevolution AT molinsøren persistentbacterialinfectionsantibiotictreatmentfailureandmicrobialadaptiveevolution |